Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Mackness, Bharti
Durrington, Paul N.
and
Mackness, Michael I.
1998.
Human Serum Paraoxonase.
General Pharmacology: The Vascular System,
Vol. 31,
Issue. 3,
p.
329.
Malin, Riikka
Laaksonen, Reijo
Knuuti, Juhani
Janatuinen, Tuula
Vesalainen, Risto
Nuutila, Pirjo
and
Lehtimäki, Terho
2001.
Paraoxonase genotype modifies the effect of pravastatin on high-density lipoprotein cholesterol.
Pharmacogenetics,
Vol. 11,
Issue. 7,
p.
625.
Alcântara, V M
Oliveira, L C
Réa, R R
Suplicy, H L
and
Chautard-Freire-Maia, E A
2003.
Butyrylcholinesterase and obesity in individuals with the CHE2 C5+ and CHE2 C5− phenotypes.
International Journal of Obesity,
Vol. 27,
Issue. 12,
p.
1557.
Cole, Toby B
Jampsa, Rachel L
Walter, Betsy J
Arndt, Tara L
Richter, Rebecca J
Shih, Diana M
Tward, Aaron
Lusis, Aldons J
Jack, Rhona M
Costa, Lucio G
and
Furlong, Clement E
2003.
Expression of human paraoxonase (PON1) during development.
Pharmacogenetics,
Vol. 13,
Issue. 6,
p.
357.
Canales, Amaia
and
Sánchez-Muniz, Francisco J.
2003.
Paraoxonasa, ¿algo más que una enzima?.
Medicina Clínica,
Vol. 121,
Issue. 14,
p.
537.
Granér, Marit
James, Richard W.
Kahri, Juhani
Nieminen, Markku S.
Syvänne, Mikko
and
Taskinen, Marja-Riitta
2006.
Association of Paraoxonase-1 Activity and Concentration With Angiographic Severity and Extent of Coronary Artery Disease.
Journal of the American College of Cardiology,
Vol. 47,
Issue. 12,
p.
2429.
BOMAN, HELGE
and
HABIB, ZACHARIAS
2008.
Serum cholinesterase loci E1 and E2 polymorphisms among Egyptians.
Hereditas,
Vol. 99,
Issue. 1,
p.
1.